Detraxi to develop a new solution to reduce global blood shortages

High income-growth countries like China will be the key recipient of the Detraxi biotechnology. Detraxi, a biotechnology company, is reportedly planning to develop its proprietary biotechnology solution for a range of global health challen....

LifeMax certified for treating Netherton Syndrome with LM-030

LifeMax Laboratories Inc a subsidiary of LifeMax Healthcare International Corporation, recently announced that a Novartis licensed investigational therapy, LM-030, has been granted pediatric disease designation by the FDA. The therapy is no....

Athira Pharma presents initial results from phase 1 trial of NDX-1017

The company has been looking forward to initiate larger phase 2 trials. The clinical-stage company Athira Pharma, Inc. has reportedly announced preliminary data from the phase 1 clinical trial of its lead therapeutic molecule, NDX-1017, at....

McDonald’s announces partnership with DoorDash for McDelivery services

McDonalds, the American fast food chain, recently announced expansion of its delivery options with inclusion of a new delivery partner, DoorDash and has ended its exclusive partnership with UberEats, cite sources. For the record, since 201....

Motorola enhances video security solutions portfolio with new buyout

The acquisition aims at adding new features and enhancing Motorola’s existing video security solutions portfolio. Motorola – the American multinational telecommunications giant has reportedly acquired Texas based mobile video....

Ascentage Pharma declares first patient dosed in APG-2575 trial

APG-2575 created by Ascentage Pharma is one of the rare Bcl-2 selective inhibitors in active clinical studies apart from Venetoclax. Ascentage Pharma has reportedly announced that it has dosed the first patient in a phase I medic....

MediciNova confirms Phase 3 trial of ibudilast in progressive MS

Ibudilast could be the best-in-disease drug for MS patients with unmet medical needs MediciNova, Inc., a biopharmaceutical company that develops novel therapeutics and is traded on Tokyo Stock Exchange’s JASDAQ Market and on NASDAQ G....

Accenture announces addition of 600 jobs to Chicago operations by 2022

Accenture plc, the leading professional services company that provides services in consulting, operations, strategy, digital and technology has recently announced the addition of 600 jobs to its Chicago operations by 2022. For the record, ....

CMIC becomes Align Clinical CRO member to enhance trial partnerships

The teaming up of CMIC with other companies will improve the collaboration and execution of clinical studies CMIC Group, a leading Japanese Contract Research Organization (CRO) that provides complete range of pharmaceutical drug services, ....

Taku Gold acquires high-grade Portland Gold Project in Yukon

The acquisition will support Taku’s strategy to capitalize on high-value exploration prospects within the White Gold District. Canada’s gold exploration and resource company, Taku Gold Corp. has recently announced its....